ENGLISH
La vitrine de diffusion des publications et contributions des chercheurs de l'ÉTS
RECHERCHER

Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program

Addington, Jean, Liu, Lu, Braun, Amy, Auther, Andrea, Calkins, Monica E., Cornblatt, Barbara A., Corcoran, Cheryl M., Fusar-Poli, Paolo, Kerr, Melissa J., Mourgues-Codern, Catalina V., Nunez, Angela R., Oliver, Dominic, Strauss, Gregory P., Walsh, Barbara C., Alameda, Luis K., Arango, Celso, Breitborde, Nicholas J. K., Broome, Matthew R., Cadenhead, Kristin S., Carrion, Ricardo E., Chen, Eric Yu Hai, Choi, Jimmy, Coleman, Michael J., Conus, Philippe, Diaz-Caneja, Covadonga M., Dwyer, Dominic, Ellman, Lauren M., Faghankhani, Masoomeh, Gaspar, Pablo A., Gerber, Carla, Glenthøj, Louise Birkedal, Horton, Leslie E., Hui, Christy, Jacobs, Grace R., Kambeitz, Joseph, Kambeitz-Ilankovic, Lana, Keshavan, Matcheri S., Kim, Sung-Wan, Koutsouleris, Nikolaos, Kwon, Jun Soo, Langbein, Kerstin, Lewandowski, Kathryn E., Mamah, Daniel, Marcy, Patricia J., Mathalon, Daniel H., Mittal, Vijay A., Nordentoft, Merete, Pearlson, Godfrey D., Penzel, Nora, Perez, Jesus, Perkins, Diana O., Powers, Albert R., Rogers, Jack, Sabb, Fred W., Schiffman, Jason, Shah, Jai L., Silverstein, Steven M., Smesny, Stefan, Stone, William S., Thompson, Andrew, Thompson, Judy L., Upthegrove, Rachel, Verma, Swapna, Wang, Jijun, Wastler, Heather M., Wickham, Alana, Rossum, Inge Winter-van, Wolf, Daniel H., Bouix, Sylvain, Pasternak, Ofer, Kahn, Rene S., Bearden, Carrie E., Kane, John M., McGorry, Patrick D., Buccilli, Kate, Nelson, Barnaby, Shenton, Martha E., Woods, Scott W. et Yung, Alison R.. 2025. « Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program ». Schizophrenia, vol. 11, nº 1.
Compte des citations dans Scopus : 7.

[thumbnail of Bouix-S-2025-30830.pdf]
Prévisualisation
PDF
Bouix-S-2025-30830.pdf - Version publiée
Licence d'utilisation : Creative Commons CC BY-NC-ND.

Télécharger (2MB) | Prévisualisation

Résumé

Clinical ascertainment and clinical outcome are key features of any large multisite study. In the ProNET and PRESCIENT research networks, the Accelerating Medicines Partnership® Schizophrenia (AMP®SCZ) Clinical Ascertainment and Outcome Measures Team aimed to establish a harmonized clinical assessment protocol across these two research networks and to define ascertainment criteria and primary and secondary endpoints. In addition to developing the assessment protocol, the goals of this aspect of the AMP SCZ project were: (1) to implement and monitor clinical training, ascertainment of participants, and clinical assessments; (2) to provide expert clinical input to the Psychosis Risk Evaluation, Data Integration and Computational Technologies: Data Processing, Analysis, and Coordination Center (PREDICT-DPACC) for data collection, quality control, and preparation of data for the analysis of the clinical measures; and (3) to provide ongoing support to the collection, analysis, and reporting of clinical data. This paper describes the (1) protocol clinical endpoints and outcomes, (2) rationale for the selection of the clinical measures, (3) extensive training of clinical staff, (4) preparation of clinical measures for a multisite study which includes several sites where English is not the native language; and (5) the assessment of measure stability over time in the AMP SCZ observational study comparing clinical ratings at baseline and at the 2-month follow up. Watch Dr. Jean Addington discuss her work and this article: https://vimeo.com/1040425281

Type de document: Article publié dans une revue, révisé par les pairs
Professeur:
Professeur
Bouix, Sylvain
Affiliation: Génie logiciel et des technologies de l'information
Date de dépôt: 17 avr. 2025 16:09
Dernière modification: 23 avr. 2025 18:44
URI: https://espace2.etsmtl.ca/id/eprint/30830

Actions (Authentification requise)

Dernière vérification avant le dépôt Dernière vérification avant le dépôt